Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005579 220002182 null null Palliative (P) 2014-01-25 2014-01-27 Cytarabine Low Dose N N 220028504 CYTARABINE
220005580 220002182 0 58 Palliative (P) 2017-10-16 2017-10-16 Cytarabine low (10to20mg/m2) IV/SC 02 N 220028504 CYTARABINE
220005583 220002184 1.63 80.8 Curative (C) 2015-09-12 2015-09-19 AML17 TRIAL N N 220028513 AML17 TRIAL
220005584 220002184 1.63 54.8 Curative (C) null 2017-05-18 AML17 TRIAL N N 220028513 AML17 TRIAL
220005585 220002185 0 null Curative (C) 2015-12-11 2015-12-11 AML17 TRIAL N N 220028517 AML17 TRIAL
220005586 220002185 1.68 95.4 Curative (C) 2015-03-13 2015-03-13 Trial Unspecified 1 N 220028517 TRIAL
220005587 220002185 null 72.7 Palliative (P) 2013-05-30 2013-06-05 Cytarabine low (10to20mg/m2) IV/SC 02 N 220028517 CYTARABINE
220005588 220002185 null 69 Curative (C) null 2016-03-03 Trial Unspecified Y N 220028517 TRIAL
220005589 220002186 1.67 88.6 Curative (C) null 2013-04-18 AML17 TRIAL N N 220028526 AML17 TRIAL
220005590 220002186 1.57 74 null null 2013-11-13 Cytarabine Low Dose 2 N 220028526 CYTARABINE
220005591 220002187 1.77 111 Curative (C) 2017-01-24 2017-01-24 AML17 TRIAL N N 220028529 AML17 TRIAL
220005592 220002188 null 69.4 Disease modification (D) 2017-12-30 2017-12-30 Trial Unspecified 01 N 220028533 TRIAL
220005593 220002188 1.7 82.1 Curative (C) 2017-01-15 2017-01-15 Trial Unspecified Y N 220028533 TRIAL
220005594 220002188 1.83 97.8 Curative (C) 2016-11-14 2016-11-15 Trial Unspecified Y N 220028533 TRIAL
220005595 220002188 null null Palliative (P) 2015-04-01 2015-04-01 Cytarabine low (10to20mg/m2) IV/SC Y N 220028533 CYTARABINE
220005598 220002190 1.77 104 Palliative (P) 2015-04-01 2015-04-01 Cytarabine low (10to20mg/m2) IV/SC N N 220028547 CYTARABINE
220005599 220002190 1.65 45 Palliative (P) 2017-06-14 2017-06-14 Cytarabine Low Dose 02 N 220028547 CYTARABINE
220005600 220002191 1.74 77.5 Curative (C) 2016-02-17 2016-02-22 AML17 TRIAL N N 220028552 AML17 TRIAL
220005601 220002192 1.73 64.4 Curative (C) 2016-03-10 2016-03-10 AML17 TRIAL Y N 220028553 AML17 TRIAL
220005602 220002193 1.68 62.4 Curative (C) 2013-12-03 2013-12-07 AML17 TRIAL 1 null 220028558 AML17 TRIAL
220005603 220002193 1.79 58.4 Not known (9) 2013-07-06 2013-07-07 AML17 TRIAL 02 N 220028558 AML17 TRIAL
220005604 220002193 1.71 69.6 Curative (C) 2017-06-17 2017-06-18 AML17 TRIAL N N 220028558 AML17 TRIAL
220005605 220002193 null 88.3 Curative (C) 2017-04-24 2017-04-24 AML17 TRIAL 01 N 220028558 AML17 TRIAL
220005606 220002193 1.65 null Curative (C) 2012-12-25 2013-01-22 Cytarabine Low Dose 02 null 220028558 CYTARABINE
220005607 220002193 1.31 98 Not known (9) null 2015-01-20 AML17 TRIAL N N 220028558 AML17 TRIAL
220005608 220002194 null null Curative (C) 2016-01-20 2016-01-20 Trial Unspecified N N 220028567 TRIAL
220005609 220011201 null null Curative (C) 2017-11-18 2017-11-21 Trial Unspecified 01 null 220028571 TRIAL
220005610 220002195 null 88 Curative (C) 2014-02-17 2014-02-19 Trial Unspecified Y N 220028572 TRIAL
220005611 220011202 1.73 86.8 null 2017-11-09 2017-11-09 CYTARABINE 99 N 220028574 CYTARABINE
220005612 220011202 1.82 60.3 Curative (C) 2014-02-25 2014-03-07 Trial Unspecified 1 N 220028574 TRIAL
220005613 220002196 1.56 91.5 Curative (C) 2014-06-10 2014-06-10 AML17 TRIAL Y null 220028579 AML17 TRIAL
220005614 220011203 1.66 51.5 Palliative (P) 2014-01-23 2014-01-23 Cytarabine Low Dose N N 220028580 CYTARABINE
220005615 220011203 0 null Disease modification (D) 2016-02-16 2016-02-17 Cytarabine low (10to20mg/m2) IV/SC N N 220028580 CYTARABINE
220005616 220002197 1.77 55 Curative (C) 2015-03-26 2015-03-27 Trial Unspecified Y N 220028584 TRIAL
220005617 220011204 1.75 null Disease modification (D) 2015-06-15 2015-06-23 CYTARABINE N N 220028585 CYTARABINE
220005618 220002198 1.52 79.4 Disease modification (D) null 2013-06-14 Trial Unspecified Y Y 220028590 TRIAL
220005619 220002199 null 64.8 Palliative (P) 2014-01-25 2014-01-26 Cytarabine Low Dose N null 220028599 CYTARABINE
220005620 220002200 null 80.9 Disease modification (D) 2015-10-21 2015-10-21 Trial Unspecified 1 N 220028601 TRIAL
220005621 220002200 1.73 79.4 Curative (C) 2014-09-01 2014-09-01 Trial Unspecified Y null 220028601 TRIAL
220005622 220002200 0 62.5 null 2013-05-04 2013-05-04 CYTARABINE 1 N 220028601 CYTARABINE
220005623 220002201 1.69 null Curative (C) 2014-07-18 2014-07-18 Cytarabine Low Dose N N 220028611 CYTARABINE
220005624 220002201 1.69 0 Not known (9) 2015-02-14 2015-02-14 Cytarabine Low Dose N N 220028611 CYTARABINE
220005625 220002202 1.59 null Palliative (P) 2015-03-24 2015-03-26 Cytarabine Low Dose Y null 220028614 CYTARABINE
220005626 220002202 1.73 76.3 Not known (9) 2017-07-18 2017-07-20 Cytarabine Low Dose Y N 220028614 CYTARABINE
220005627 220002202 1.88 null Curative (C) 2018-04-25 2018-04-25 Cytarabine low (10to20mg/m2) IV/SC N N 220028614 CYTARABINE
220005628 220002203 1.68 82.3 Curative (C) 2017-07-27 2017-08-01 AML17 TRIAL 1 N 220028627 AML17 TRIAL
220005629 220002203 0 92 Disease modification (D) 2013-09-03 2013-09-03 Cytarabine Low Dose 2 N 220028627 CYTARABINE
220005630 220002204 null 87 Curative (C) 2013-07-16 2013-07-16 AML17 TRIAL 02 N 220028630 AML17 TRIAL
220005631 220002204 null null Curative (C) 2015-08-28 2015-08-28 AML17 TRIAL 02 N 220028630 AML17 TRIAL
220005632 220002204 1.6 74.5 Disease modification (D) 2015-01-21 2015-01-23 Trial Unspecified 1 N 220028630 TRIAL